Friedenthal Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-396
Closed -$9.61K 311
2025
Q2
$9.61K Hold
396
0.01% 190
2025
Q1
$10K Buy
+396
New +$10.4K 0.01% 174
2024
Q1
Sell
-300
Closed -$8.64K 273
2023
Q4
$8.64K Buy
+300
New +$9.07K 0.01% 196

Other funds holding PFE

Friedenthal Financial's PFE Position: Q3 2025 in Review

Friedenthal Financial sold out of Pfizer (PFE) in Q3 2025, closing a stake of 396 shares — an estimated $9.61K sold.

Friedenthal Financial first reported a position in PFE in Q4 2023 and held it in 3 quarters. The position peaked at $10K in Q1 2025. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Friedenthal Financial reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Friedenthal Financial sold 396 Pfizer shares in Q3 2025, an estimated $9.61K.
  • Friedenthal Financial first reported a position in Pfizer in Q4 2023 and held it in 3 quarters.
  • Friedenthal Financial's Pfizer position peaked at $10K in Q1 2025.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Friedenthal Financial's 13F filing for Q3 2025, filed 15 Oct 2025.